Related Experiment Video
Updated: Jun 6, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications
1Department of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany. ravens@rcs.urz.tu-dresden.de
Selective blockade of ultrarapid delayed rectifier potassium channels (I(Kur)) aims to treat atrial fibrillation. However, challenges in drug selectivity and channel function complicate their therapeutic use.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Pharmacology
Background:
- Ultrarapid delayed rectifier potassium channels (I(Kur)) are crucial for atrial repolarization, making them attractive targets for atrial-selective antiarrhythmic drugs.
- Blocking I(Kur) channels is hypothesized to prolong the atrial effective refractory period without causing adverse ventricular effects.
Purpose of the Study:
- To review the properties of I(Kur) channels in various expression systems and native cardiomyocytes.
- To discuss the challenges and new developments in I(Kur) channel blocker research for atrial fibrillation treatment.
Main Methods:
- Overview of I(Kur) channel structure, including pore-forming Kv1.5 α-subunits and regulatory β-subunits (Kvβ1.2, Kvβ1.3, Kvβ2.1).
- Analysis of factors complicating I(Kur) channel blocker investigation, such as current overlap (I(Kur) vs. I(to)), lack of drug selectivity, and disease-related channel regulation.
Main Results:
- I(Kur) channel function is modulated by specific α- and β-subunit compositions.
- Significant overlap with other currents and poor drug selectivity present hurdles for developing effective I(Kur) blockers.
- Disease states can alter I(Kur) channel regulation, further complicating therapeutic strategies.
Conclusions:
- While I(Kur) channels are promising targets, pure I(Kur) channel blockade may be insufficient for effectively suppressing atrial fibrillation.
- Further research into selective compounds and understanding disease-induced channel modulation is necessary for successful antiarrhythmic drug development.
More Related Videos
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
11:32Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...